Epidural Anesthetic Drugs and Devices Market Size, Share, Growth, And Industry Analysis, By Type (Epidural Anesthetic Drugs and Epidural Anesthetic Device), By Application (Abdomen Procedures, Pelvic Procedures, Lower Extremity Procedures and Others), Regional Insights, and Forecast To 2031

Updated On: 08 April 2024

Epidural Anesthetic Drugs and Devices Market Report Overview

• 

• Request a Free Sample to learn more about this report

The global epidural anesthetic drugs and devices market size was USD 530.3 million in 2022 and market is projected to touch USD 816 million by 2031, at a CAGR of 4.9% during the forecast period.

A regional anesthetic called an epidural is administered into the epidural space, a region with a thin wall around the spinal cord. During labor or surgery, for instance, epidural anesthetic medicines are used to suppress pain in a particular area of the body. They are administered by an epidural catheter, a tiny tube that is introduced into the epidural area via a tiny hole in the back. Bupivacaine, lidocaine, and fentanyl are the three most often used epidural anesthetic medications. They function by preventing the brain from receiving pain signals while preserving the patient's consciousness and mobility.

The market for epidural anesthetic drugs and devices is expanding for a number of reasons. The rising need for pain control throughout labor and other forms of surgery is a significant contributing factor. An additional aspect is the rising percentage of outpatient procedures. Additionally, the sector for epidural medications and devices is expanding due to the growing acceptance of new technology. The market for pharmaceuticals and devices is growing steadily as a result of a combination of these reasons, and this trend is anticipated to continue.

COVID-19 Impact: Decrease in Need for Epidural Drugs as an Outcome of the Pandemic

The market for epidural anesthetic drugs and devices has been significantly impacted by the COVID-19 outbreak. Lockdowns and social segregation policies had a significant impact on the number of operations and procedures, especially those requiring epidural anesthesia, and many elective operations, including orthopedic, spine, and pain management surgery, were postponed as a result. The need for epidural medications and equipment decreased as a result.

Latest Trends

"Rise in Use of Telemedicine Solutions as they Benefit Patients to Obtain Anesthetic Remotely"

The market for epidural anesthetic drugs and devices now exhibits a number of trends. The market for anesthetic medications and devices is seeing a rise in the use of telemedicine solutions. The delivery of health-related data and services using digital telecommunications and data technology is known as telemedicine, also referred to as telehealth. Those in distant or underserved locations may benefit most from telemedicine since it can help patients obtain epidural anesthetic remotely.

Epidural Anesthetic Drugs and Devices Market Segmentation

• 

• Request a Free Sample to learn more about this report

• By Type Analysis

According to type, the market can be segmented into Epidural Anesthetic Drugs and Epidural Anesthetic Device

• By Application Analysis

Based on application, the market can be divided into Abdomen Procedures, Pelvic Procedures, Lower Extremity Procedures and Others 

Driving Factors

"Growing Utilization during Labor and Pain Management Procedures are Driving the Market "

A growth in demand for epidural anesthetic drugs and devices is being brought on by the fact that epidural anesthesia is thought to be a secure and reliable way of treating pain throughout labor and birth as well as during operations including orthopedic, spine, and pain management procedures. In addition, more people are looking into epidural anesthesia as a viable choice for their pain management as chronic pain diseases such as osteoarthritis, cancer, and lower spine pain are becoming more common.

"Increasing Number of Outpatient Surgeries as a Result of Advances in Medical Practices"

The effectiveness and reliability of epidural anesthesia can be enhanced by the creation of new kinds of epidural tubes, such as those that contain enhanced features including temperature measurement. Additionally, more procedures are being conducted as outpatient procedures as a result of advances in medical practices and technologies, which is raising demand for epidural anesthesia since it enables patients to recover rapidly and go home the same day. These elements are fueling the epidural anesthetic drugs and devices market growth.

Restraining Factors

"Several Side Effects and the High Cost of the Drugs are Factors Preventing the Market from Growing"

Epidural anesthesia carries several dangers and drawbacks, including the potential for migraines, bleeding, and loss of feeling, which may discourage several individuals and doctors from opting for this type of pain relief. A further drawback for some healthcare professionals and patients is the cost of anesthetic medicines, which is a fairly expensive way of pain control.

Epidural Anesthetic Drugs and Devices Market Regional Insights

• 

• Request a Free Sample to learn more about this report

"High Prevalence of Operations and Rising Use of Technological Innovation are Promoting the North American Market"

At the moment, the epidural anesthetic drugs and devices market share is led by North America. This is caused by a variety of elements, including a high prevalence of operations needing epidural anesthetic, a sizable quantity of skilled medical personnel, and sophisticated medical infrastructure. Due to the rising use of technological innovations for pain control, the United States is the most significant market in North America for anesthetic medications and equipment. Additionally, there are many clinics and hospitals in the nation, which increases the need for these medications. Moreover, the presence of significant companies in the area is fostering the market's expansion in North America.

Key Industry Players

"Key Players Focus on Investing R&D Activities as well as M&A to Diversify their Product Offering"

Key competitors in the market for medications and devices for epidural anesthesia are employing a number of techniques to enhance their market share. In order to distinguish their products and acquire a competitive edge, businesses are investing in R&D to produce new and superior epidural medications and devices. To diversify their product offering, they are also taking part in acquisitions and mergers. Additionally, the businesses are promoting their products through a variety of marketing and promotional efforts at trade shows. Finally, the companies are making investments in developing markets including Latin America, Asia Pacific, and the Middle East to meet the region's rising need for epidural anesthetic drugs and devices.

List of Market Players Profile

• Taj Pharmaceuticals Ltd (India)
• Pfizer (U.S.)
• Fresenius Kabi (Germany)
• Areva Pharmaceuticals Inc. (U.S.)
• Farco Pharma GmbH (Germany)
• Mahendra Chemicals (India)
• Aurobindo Pharma Ltd (India)
• Amphastar Pharmaceuticals, Inc. (U.S.)
• B.Braun (Germany)

Report Coverage

This report covers the epidural anesthetic drugs and devices market. The CAGR expected to be in during the forecast period, and also the USD value in 2022 and what it is expected to be in 2031. The effect COVID-19 had on the market in the beginning of the pandemic. The latest trends taking place in this industry. The factors that are driving this market as well as the factors that are restraining the growth of industry. The segmentation of this market based on type and applications. The region leading in the industry and why they will continue to do so during the forecast period. Further, the key market players, what all is being done by them to stay ahead of their competition as well as retain their market positions. All these details are covered in the report.